These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13737718)

  • 21. Adjunctive use of antidepressants in a variety of medical problems.
    BATTERMAN RC
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():86-7. PubMed ID: 13687795
    [No Abstract]   [Full Text] [Related]  

  • 22. [1-Benzyl-1,2,5-methyl-3-isoxazolylcarbonylhydrazine, a monoaminooxidase inhibitor, in the treatment of 84 depressed patients].
    DE LA FUENTE MUNIZ R; FONCERRADA M; MARTINEZ CID E
    Rev Invest Clin; 1960; 12():591-604. PubMed ID: 13720580
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychic energizers in the depressed patient.
    SENSEMAN LA
    R I Med J; 1961 Apr; 44():217-9. PubMed ID: 13750119
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative cardiovascular effects of monoamine oxidase inhibitors. Pharmacological effects. Action on cardiac dynamics and metabolism].
    CAHN J; HEROLD M
    Agressologie; 1960 Dec; 1():579-93. PubMed ID: 13689801
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of nialamide and ethyl alcohol on some personality, cognitive and psychomotor variables in normal volunteers.
    CAIRD WK; SLOANE RB; INGLIS J
    J Neuropsychiatr; 1960; 2():31-4. PubMed ID: 13689836
    [No Abstract]   [Full Text] [Related]  

  • 26. Action of monoamine oxidase inhibitors on dehydrogenases.
    REDETZKI H; O'BOURKE F
    Arch Int Pharmacodyn Ther; 1961 Mar; 130():299-303. PubMed ID: 13740200
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monoamine oxidase inhibitors].
    PLETSCHER A; GEY KF; ZELLER P
    Fortschr Arzneimittelforsch; 1960; 2():417-590. PubMed ID: 13736336
    [No Abstract]   [Full Text] [Related]  

  • 28. beta-Phenylisopropylhydrazine, a potent and long acting monoamine oxidase inhibitor.
    HORITA A
    J Pharmacol Exp Ther; 1958 Feb; 122(2):176-81. PubMed ID: 13514605
    [No Abstract]   [Full Text] [Related]  

  • 29. Depression--its treatment with etryptamine acetate.
    SETTEL E
    J Am Geriatr Soc; 1961 Sep; 9():755-8. PubMed ID: 13750393
    [No Abstract]   [Full Text] [Related]  

  • 30. Alpha-ethyltryptamine acetate in the treatment of depression, a study of the methodology of drug evaluation.
    KAST EC
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():114-8. PubMed ID: 13751710
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical studies with ethyltryptamine.
    TURNER WJ; MERLIS S
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():73-6. PubMed ID: 13778759
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experiences with etryptamine in office practice.
    MALETZ L
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():58-60. PubMed ID: 13765760
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibitors of monoamine oxidases: pharmacological properties and clinical effects of beta-phenylisopropylhydrazine and of nialamide].
    GRATTAROLA FR; ROVERA GG
    Riv Patol Nerv Ment; 1960; 81():303-18. PubMed ID: 13707969
    [No Abstract]   [Full Text] [Related]  

  • 34. [Monoamino-oxidase inhibitors].
    PLETSCHER A
    Dtsch Med Wochenschr; 1961 Apr; 86():647-57. PubMed ID: 13736342
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the mechanism of action of inhibitors of monoamino-oxidase in the brain].
    PLETSCHER A
    Therapie; 1960; 15():839-44. PubMed ID: 13736343
    [No Abstract]   [Full Text] [Related]  

  • 36. Current trends in the use of monoamine oxidase inhibitors in depression.
    PRANGE AJ
    N C Med J; 1960 Dec; 21():546-7. PubMed ID: 13737718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Monoamine oxidase inhibitors in the treatment of depressive states].
    GARRONE G; DICK P
    Psychiatr Neurol (Basel); 1960 Jul; 140():107-14. PubMed ID: 13703760
    [No Abstract]   [Full Text] [Related]  

  • 38. [On incompatibility between monoamine oxidase inhibitors and imipramin (with remarks on the work of O. Eichhorn "Remarks on psychopharmacological combined therapy" in Wien. Med. Wschr. 111, 1961, 307)].
    HARRER G
    Wien Med Wochenschr; 1961 Aug; 111():551-3. PubMed ID: 13711697
    [No Abstract]   [Full Text] [Related]  

  • 39. Some pharmacological aspects of monoamine oxidase regulators.
    HORITA A
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():141-5. PubMed ID: 13715853
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychological evaluation of monoamine oxidase inhibitor effects.
    RAFFEL SC
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():49-51. PubMed ID: 13739084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.